| Lynda Hubeny, BSN | |
|
9609 Kent Pl Unit 207, Aurora, CO 80014-7449 | |
| (702) 353-8662 | |
| Not Available |
| Full Name | Lynda Hubeny |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 9609 Kent Pl Unit 207, Aurora, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114310794 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 1622428 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lynda Hubeny, BSN 9609 Kent Pl Unit 207, Aurora, CO 80014-7449 Ph: (702) 353-8662 | Lynda Hubeny, BSN 9609 Kent Pl Unit 207, Aurora, CO 80014-7449 Ph: (702) 353-8662 |
News Archive
The Ensign Group, Inc., the parent company of the Ensign group of skilled nursing, rehabilitative care services, hospice care and assisted living companies, announced today that it has acquired Lakeland Hills Independent & Assisted Living Community, a 167-unit assisted and independent living facility in Dallas, Texas. The asset acquisition was effective on Monday, August 1, 2011.
Stealth Peptides Inc. (Stealth), a privately held biopharmaceutical company developing innovative mitochondrial therapies for diseases with unmet medical needs, presented its lead clinical candidate, Bendavia, during the 2011 American Heart Association's (AHA) Cardiovascular Scientific Sessions.
Thirty-four percent of malaria-endemic countries are complying with WHO guidelines to monitor artemisinin resistance within their borders, the agency said in a report on Thursday, CBS News reports (11/18). Reuters reports that artemisinin "is the best drug available against malaria, especially when used in artemisinin combination therapy (ACT), which combines it with other drugs that finish off the [malaria] parasite" (Nebehay, 11/18).
Survivors of a terror attack have an increased risk of frequent migraine and tension headaches after the attack, according to a study published in the December 13, 2017, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Opexa Therapeutics, Inc., a biotechnology company developing a novel T-cell therapy for multiple sclerosis (MS), today reported financial results for the year ended December 31, 2011 and provided an overview of corporate developments during the last year.
› Verified 1 days ago
Rachel Marie Ranweiler, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-6857 Fax: 720-777-7207 | |
Mrs. Wendelyn M Barrett, NNP Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-6857 | |
Stacey M Johnson, APRN Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave Fl Aip23, Aurora, CO 80045 Phone: 720-848-0000 | |
Rashina Shambe, Registered Nurse Medicare: May Accept Medicare Assignments Practice Location: 791 Chambers Rd, Aurora, CO 80011 Phone: 303-617-2300 | |
Mrs. Ellen G Buchannan, NP Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 13650 E Mississippi Ave, 120, Aurora, CO 80012 Phone: 303-695-8684 Fax: 303-597-0191 | |
Margaret Rousseau, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 23968 E Hinsdale Pl, Aurora, CO 80016 Phone: 303-866-9712 Fax: 303-766-8374 | |
Jeanne M Norman, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2500 S Havana St, Aurora, CO 80014 Phone: 303-338-3333 |